GLESATINIB

UNII:	7Q29OXD98N
Type:	INGREDIENT SUBSTANCE
Formula:	C₃₁H₂₇F₂N₅O₃S₂
Preferred Substance Name:	GLESATINIB
InChIKey:	YRCHYHRCBXNYNU-UHFFFAOYSA-N
GSRS Full Record:	7Q29OXD98N i

936694-12-1
BENZENEACETAMIDE, 4-FLUORO-N-(((3-FLUORO-4-((2-(5-(((2-METHOXYETHYL)AMINO)METHYL)-2-PYRIDINYL)THIENO(3,2-B)PYRIDIN-7-YL)OXY)PHENYL)AMINO)THIOXOMETHYL)-
GLESATINIB [USAN]
Glesatinib [WHO-DD]
MG-90265
MG-90265X
MG90265
MG90265X
MGCD-265
MGCD265
N-(3-FLUORO-4-(2-(5-((2-METHOXYETHYLAMINO) METHYL)PYRIDINE-2-YL)THIENO(3,2-B)PYRIDINE-7-YLOXY)PHENYLCARBAMOTHIOYL)-2-(4-FLUOROPHENYL)ACETAMIDE
N-[[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]-2-pyridinyl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]carbamothioyl]-2-(4-fluorophenyl)acetamide
N-[[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]-2-pyridinyl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]carbamothioyl]-2-(4-fluorophenyl)acetamide
glesatinib [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

GLESATINIB

Synonyms and Mappings

Resources